Gürmen, ESBilge, A2025-04-102025-04-102149-5807http://hdl.handle.net/20.500.14701/36060Dabigatran etexilate is a prodrug with anticoagulant effect through inhibition of thrombin. Although it does not require laboratory monitoring and has minimal food-drug interaction, its disadvantages are bleeding, common GIS-related side effects and the need for dosage adjustment according to the severity of liver/renal failure. We aimed to present and discuss an unusual side effect of dabigatran etexilate.EnglishArticle2149-6048